Video Experimental Relacionado
Updated: Sep 9, 2025
03:10
Author Spotlight: Development and Evaluation of a Compound Acne Rodent Model Using C. acnes and Oleic Acid
Published on: November 1, 2024
2.8K
La espironolactona para el acné: estrategias prácticas para obtener resultados clínicos óptimos
Sherry Ershadi1, John S Barbieri1
1Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
Cutis
|August 28, 2025
Resumen
La espironolactona es un tratamiento eficaz para el acné en las mujeres, ofreciendo una alternativa a los antibióticos. Esta revisión cubre su uso, dosificación y manejo de efectos secundarios para una piel más clara.
Área de la Ciencia:
- Dermatología
- Farmacología
Sus antecedentes:
- El acné vulgar afecta a muchas mujeres.
- Los antibióticos orales son comunes pero tienen limitaciones.
- La espironolactona es una opción de tratamiento sistémico poco utilizada.
Objetivo del estudio:
- Para proporcionar una visión general de la espironolactona para el tratamiento del acné.
- Para discutir la selección del paciente, la dosificación y el manejo de los efectos adversos.
- Para resaltar la espironolactona como una alternativa a los antibióticos orales.
Principales métodos:
- Revisión de los ensayos clínicos y la literatura sobre la espironolactona para el acné.
- Análisis de la eficacia para el acné facial y del tronco.
- Evaluación del perfil de seguridad y recomendaciones de seguimiento.
Principales resultados:
- La espironolactona es eficaz para varios tipos de acné en las mujeres.
- Se recomienda una dosis inicial de 100 mg/día para la eficacia y la tolerabilidad.
- Los efectos secundarios comunes son manejables y el riesgo de cáncer no aumenta.
Conclusiones:
- La espironolactona es un tratamiento valioso y poco utilizado para el acné en las mujeres.
- Existen estrategias prácticas para optimizar su uso y controlar los efectos secundarios.
- Presenta una alternativa viable a las terapias tradicionales con antibióticos.
Videos de Conceptos Relacionados
01:19Antiasthma Drugs: Leukotriene Modifiers
461
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
461
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
383
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
383
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
201
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
201
01:26Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
451
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
451
01:17Drugs Used in Lower Respiratory Disorders: Overview
575
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
575